University Hospital Tuebingen

This early-stage trial tests a new COVID-19 booster vaccine called Prime-2-CoV_Beta, made from a modified orf virus. It involves 96 healthy adults aged 18-55 who have already been vaccinated or infected. The main goal is to check safety and how well the vaccine boosts the immune …

This study explores transplanting a uterus into women who cannot get pregnant because they were born without a womb or had it removed. Ten women under 40 with a healthy donor will receive the transplant. The goal is to see if the procedure is feasible and can restore fertility, t…

This study is testing whether an artificial intelligence (AI) program can spot early signs of diabetic retinopathy—a condition that can lead to blindness—in people with prediabetes and diabetes. Researchers will take pictures of the retina and use the AI to analyze them. The goal…

Researchers are testing whether a non-invasive device that stimulates the vagus nerve through the ear can help people with Long COVID recover after exertion. The trial enrolls 120 people with persistent symptoms such as fatigue, brain fog, and shortness of breath. Participants us…

This study looks at whether adding a structured therapy journal to standard cognitive behavioral therapy (CBT) helps people with mental health conditions like depression, anxiety, or eating disorders feel better faster. About 80 adults in outpatient therapy will be randomly assig…

This study follows 90 children born very prematurely (before 32 weeks) at ages 2, 5, and 10. A team of experts checks their mental and physical health, sleep, and quality of life. Parents use an app to answer questions, and the team gives recommendations for further care. The goa…

This study aims to find better ways to measure how retinitis pigmentosa (a genetic eye disease that causes vision loss) progresses over time. Researchers will use advanced imaging and vision tests in 40 people with specific genetic forms of the disease. The goal is to identify re…

This study tests whether artificial intelligence can predict malignant brain edema, a life-threatening swelling, in patients who have had a major stroke. Researchers will analyze CT scans and clinical data from over 1,600 patients to see if the AI can identify early warning signs…